Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SINGLE-CHAIN UROKINASE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 104 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Guerrero, B; Arocha-Pinango, CL; Pinto, MA; Muller, CA; San Juan, AG; Amorim, S; Perales, J
      Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model

      BLOOD COAGULATION & FIBRINOLYSIS
    2. Choi-Miura, NH; Yoda, M; Saito, K; Takahashi, K; Tomita, M
      Identification of the substrates for plasma hyaluronan binding protein

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    3. Poliakov, A; Tkachuk, V; Ovchinnikova, T; Potapenko, N; Bagryantsev, S; Stepanova, V
      Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation

      BIOCHEMICAL JOURNAL
    4. Jiao, JW; Yu, MM; Ru, BG
      Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    5. Li, CZ; Zhang, J; Jiang, YP; Gurewich, V; Chen, YH; Liu, JN
      Urokinase-type plasminogen activator up-regulates its own expression by endothelial cells and monocytes via the u-PAR pathway

      THROMBOSIS RESEARCH
    6. Andreotti, F; Patrizi, R; Buffon, A; Crea, F; Maseri, A; Kluft, C; Dooijewaard, G
      Coronary artero-venous gradient of endogenous urokinase

      THROMBOSIS RESEARCH
    7. Schenk-Braat, EAM; Morser, J; Rijken, DC
      Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    8. Collen, D; Lijnen, HR
      Recent developments in thrombolytic therapy

      FIBRINOLYSIS & PROTEOLYSIS
    9. Vines, DJ; Lee, SW; Dichek, DA; Ellis, V
      Receptor-mediated regulation of plasminogen activator function: Plasminogen activation by two directly membrane-anchored forms of urokinase

      JOURNAL OF PEPTIDE SCIENCE
    10. Lijnen, HR; Collen, D
      Molecular basis of thrombolytic therapy

      JOURNAL OF NUCLEAR CARDIOLOGY
    11. Wang, P; Zhang, J; Sun, ZY; Chen, YH; Liu, JN
      Glycosylation of prourokinase produced by Pichia pastoris impairs enzymatic activity but not secretion

      PROTEIN EXPRESSION AND PURIFICATION
    12. Chun, MH
      Serum signaling factors and spheroids

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    13. Torchilin, VP
      Drug targeting

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    14. Haj-Yehia, A; Nassar, T; Sachais, BS; Kuo, A; Bdeir, K; Al-Mehdi, AB; Mazar, A; Cines, DB; Higazi, AA
      Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo

      FASEB JOURNAL
    15. Aisina, RB; Moukhametova, LI; Firsova, EF; Varfolomeyev, SD
      Prolonged plasma clot lysis induced by acyl-derivatives of urokinase in vitro

      APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
    16. Jiang, PC; Changgeng, R; Ru, BG
      Construction and expression of antibody targeted plasminogen activator

      ENZYME AND MICROBIAL TECHNOLOGY
    17. Wan, HY; Liu, ZH; Xia, XB; Gu, JM; Wang, B; Liu, XJ; Zhu, MQ; Li, PX; Ruan, CG
      A recombinant antibody-targeted plasminogen activator with high affinity for activated platelets increases thrombolytic potency in vitro and in vivo

      THROMBOSIS RESEARCH
    18. Wang, P; Zhang, J; Sun, ZY; Chen, YH; Gurewich, V; Liu, JN
      Catalytic and fibrinolytic properties of recombinant urokinase plasminogenactivator from E-coli, mammalian, and yeast cells

      THROMBOSIS RESEARCH
    19. Ries, M; Zenker, M; Gaffney, PJ
      Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system

      THROMBOSIS RESEARCH
    20. Bdeir, K; Kuo, A; Mazar, A; Sachais, BS; Xiao, WZ; Gawlak, S; Harris, S; Higazi, A; Cines, DB
      A region in domain II of the urokinase receptor required for urokinase binding

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. Shliom, O; Huang, M; Sachais, B; Kuo, A; Weisel, JW; Nagaswami, C; Nassar, T; Bdeir, K; Hiss, E; Gawlak, S; Harris, S; Mazar, A; Higazi, AA
      Novel interactions between urokinase and its receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    22. Bdeir, K; Murciano, JC; Tomaszewski, J; Koniaris, L; Martinez, J; Cines, DB; Muzykantov, VR; Higazi, AAR
      Urokinase mediates fibrinolysis in the pulmonary microvasculature

      BLOOD
    23. Qian, B; Sun, YQ; Guo, Y; Dang, X; Ru, BG
      A prourokinase-RGDS chimera - Construction, expression and characterization

      SCIENCE IN CHINA SERIES C-LIFE SCIENCES
    24. Weitz, JI; Stewart, RJ; Fredenburgh, JC
      Mechanism of action of plasminogen activators

      THROMBOSIS AND HAEMOSTASIS
    25. Ruef, J; Nordt, TK; Peter, K; Runge, MS; Kubler, W; Bode, C
      A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregation

      THROMBOSIS AND HAEMOSTASIS
    26. Szarka, SJ; Sihota, EG; Habibi, HR; Wong, SL
      Staphylokinase as a plasminogen activator component in recombinant fusion proteins

      APPLIED AND ENVIRONMENTAL MICROBIOLOGY
    27. Schwartz, BS; Espana, F
      Two distinct urokinase-serpin interactions regulate the initiation of cellsurface-associated plasminogen activation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    28. CAO Y; SURESH MR
      BISPECIFIC ANTIBODIES AS NOVEL BIOCONJUGATES

      Bioconjugate chemistry
    29. MUIR E; DU JS; FOKSEANG J; SMITHTHOMAS LC; HOUSDEN ES; ROGERS J; FAWCETT JW
      INCREASED AXON GROWTH THROUGH ASTROCYTE CELL-LINES TRANSFECTED WITH UROKINASE

      Glia
    30. SAKAMOTO T; SPEE C; SCURIC Z; GORDON EM; HINTON DR; ANDERSON WF; RYAN SJ
      ABILITY OF RETROVIRAL TRANSDUCTION TO MODIFY THE ANGIOGENIC CHARACTERISTICS OF RPE CELLS

      Graefe's archive for clinical and experimental ophthalmology
    31. KIENAST J; PADRO T; STEINS M; LI CX; SCHMID KW; HAMMEL D; SCHELD HH; VANDELOO JCW
      RELATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION TO PRESENCE AND SEVERITY OF ATHEROSCLEROTIC LESIONS IN HUMAN CORONARY-ARTERIES

      Thrombosis and haemostasis
    32. DELZOPPO GJ; HIGASHIDA RT; FURLAN AJ; PESSIN MS; ROWLEY HA; GENT M
      PROACT - A PHASE-II RANDOMIZED TRIAL OF RECOMBINANT PROUROKINASE BY DIRECT ARTERIAL DELIVERY IN ACUTE MIDDLE CEREBRAL-ARTERY STROKE

      Stroke
    33. ZHANG JC; SAKTHIVEL R; KNISS D; GRAHAM CH; STRICKLAND DK; MCCRAE KR
      THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN ALPHA(2)-MACROGLOBULIN RECEPTOR REGULATES CELL-SURFACE PLASMINOGEN-ACTIVATOR ACTIVITY ON HUMAN TROPHOBLAST CELLS/

      The Journal of biological chemistry
    34. NGUYEN DHD; HUSSAINI IM; GONIAS SL
      BINDING OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR TO ITS RECEPTOR IN MCF-7 CELLS ACTIVATES EXTRACELLULAR SIGNAL-REGULATED KINASE-1 AND KINASE-2 WHICH IS REQUIRED FOR INCREASED CELLULAR MOTILITY

      The Journal of biological chemistry
    35. ALEXANDER DS; SIPLEY JD; QUIGLEY JP
      AUTOACTIVATION OF AVIAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) - A NOVEL MODE OF INITIATION OF THE UPA PLASMIN CASCADE/

      The Journal of biological chemistry
    36. ODA M; SHIRAISHI A; HASEGAWA M
      ANALYSIS OF THE TERNARY COMPLEX-FORMATION OF HUMAN UROKINASE WITH THESEPARATED 2 DOMAINS OF ITS RECEPTOR

      European journal of biochemistry
    37. HIGAZI AA; BDEIR K; HISS E; ARAD S; KUO A; BARGHOUTI I; CINES DB
      LYSIS OF PLASMA CLOTS BY UROKINASE-SOLUBLE UROKINASE RECEPTOR COMPLEXES

      Blood
    38. CHAVAKIS T; KANSE SM; YUTZY B; LIJNEN HR; PREISSNER KT
      VITRONECTIN CONCENTRATES PROTEOLYTIC ACTIVITY ON THE CELL-SURFACE ANDEXTRACELLULAR-MATRIX BY TRAPPING SOLUBLE UROKINASE RECEPTOR UROKINASECOMPLEXES

      Blood
    39. SUN ZY; LIU BF; CHEN YH; GUREWICH V; ZHU DX; LIU JN
      ANALYSIS OF THE FORCES WHICH STABILIZE THE ACTIVE CONFORMATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR

      Biochemistry
    40. CINES DB; POLLAK ES; BUCK CA; LOSCALZO J; ZIMMERMAN GA; MCEVER RP; POBER JS; WICK TM; KONKLE BA; SCHWARTZ BS; BARNATHAN ES; MCCRAE KR; HUG BA; SCHMIDT AM; STERN DM
      ENDOTHELIAL-CELLS IN PHYSIOLOGY AND IN THE PATHOPHYSIOLOGY OF VASCULAR DISORDERS

      Blood
    41. EMEIS JJ; VERHEIJEN JH; RONDAY HK; DEMAAT MPM; BRAKMAN P
      PROGRESS IN CLINICAL FIBRINOLYSIS

      Fibrinolysis & proteolysis
    42. BODE C; NORDT TK; PETER K; RUEF J; RUNGE MS; KUBLER W
      TARGETING OF THROMBOLYTIC AND ANTITHROMBOTIC AGENTS

      Fibrinolysis & proteolysis
    43. BODE C; PETER K; NORDT T; KOHLER B; MOSER M; RUEF J; RUNGE MS
      NEW DEVELOPMENTS IN THROMBOLYTIC THERAPY

      Fibrinolysis & proteolysis
    44. KANSE SM; BENZAKOUR O; KANTHOU C; KOST C; LIJNEN HR; PREISSNER KT
      INDUCTION OF VASCULAR SMC PROLIFERATION BY UROKINASE INDICATES A NOVEL MECHANISM OF ACTION IN VASOPROLIFERATIVE DISORDERS

      Arteriosclerosis, thrombosis, and vascular biology
    45. ELLIS V
      CELLULAR RECEPTORS FOR PLASMINOGEN ACTIVATORS - RECENT ADVANCES

      Trends in cardiovascular medicine
    46. TANG W; SUN ZY; PANNELL R; GUREWICH V; LIU JN
      AN EFFICIENT SYSTEM FOR PRODUCTION OF RECOMBINANT UROKINASE-TYPE PLASMINOGEN-ACTIVATOR

      Protein expression and purification
    47. CHUN MH
      PLASMIN INDUCES THE FORMATION OF MULTICELLULAR SPHEROIDS OF BREAST-CANCER CELLS

      Cancer letters
    48. HIGAZI AAR; MAZAR A; WANG JY; QUAN N; GRIFFIN R; REILLY R; HENKIN J; CINES DB
      SOLUBLE HUMAN UROKINASE RECEPTOR IS COMPOSED OF 2 ACTIVE UNITS

      The Journal of biological chemistry
    49. SUN ZY; JIANG YP; MA Z; WU H; LIU BF; XU YM; TANG W; CHEN YH; LI CZ; ZHU DX; GUREWICH V; LIU JN
      IDENTIFICATION OF A FLEXIBLE LOOP REGION-(297-313) OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, WHICH HELPS DETERMINE ITS CATALYTIC ACTIVITY

      The Journal of biological chemistry
    50. FUKAO H; UESHIMA S; OKADA K; MATSUO O
      THE ROLE OF THE PERICELLULAR FIBRINOLYTIC SYSTEM IN ANGIOGENESIS

      Japanese Journal of Physiology
    51. WANG JY; MAZAR A; QUAN N; SCHNEIDER A; HENKIN J
      PLASMINOGEN ACTIVATION BY PROUROKINASE IN COMPLEX WITH ITS RECEPTOR -DEPENDENCE ON A TRIPEPTIDE (SPECTROZYME PLASMIN)

      European journal of biochemistry
    52. FUJISE K; REVELLE BM; STACY L; MADISON EL; YEH ETH; WILLERSON JT; BECK PJ
      A TISSUE-PLASMINOGEN ACTIVATOR P-SELECTIN FUSION PROTEIN IS AN EFFECTIVE THROMBOLYTIC AGENT/

      Circulation
    53. EVANS CP; ELFMAN F; PARANGI S; CONN M; CUNHA G; SHUMAN MA
      INHIBITION OF PROSTATE-CANCER NEOVASCULARIZATION AND GROWTH BY UROKINASE-PLASMINOGEN ACTIVATOR RECEPTOR BLOCKADE

      Cancer research
    54. ALEXANDER DS; AIMES RT; QUIGLEY JP
      WHAT STRUCTURE AND FUNCTION OF AVIAN PLASMINOGEN-ACTIVATOR AND MATRIXMETALLOPROTEINASE-2 REVEAL ABOUT THEIR COUNTERPART MAMMALIAN ENZYMES,THEIR REGULATION AND THEIR ROLE IN TUMOR INVASION

      Enzyme & protein
    55. BODE C; GULBA D; HUBER K; RUNGE MS
      NEW APPROACHES IN PLASMINOGEN-ACTIVATOR THERAPY

      Annals of hematology
    56. TSUJIKAWA M; OKABAYASHI K; MORITA M; TANABE T
      SECRETION OF A VARIANT OF HUMAN SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR WITHOUT AN N-GLYCOSYLATION SITE IN THE METHYLOTROPHIC YEAST, PICHIA-PASTORIS AND CHARACTERIZATION OF THE SECRETED PRODUCT

      Yeast
    57. FOX D; OURIEL K; GREEN RM; STOUGHTON J; RIGGS P; CIMINO C
      THROMBOLYSIS WITH PROUROKINASE VERSUS UROKINASE - AN IN-VITRO COMPARISON

      Journal of vascular surgery
    58. WNENDT S; JANOCHA E; SCHNEIDER J; STEFFENS GJ
      CONSTRUCTION AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF CHIMERIC PROUROKINASE DERIVATIVES WITH INTRINSIC THROMBIN-INHIBITORY POTENTIAL

      Protein engineering
    59. RESNATI M; GUTTINGER M; VALCAMONICA S; SIDENIUS N; BLASI F; FAZIOLI F
      PROTEOLYTIC CLEAVAGE OF THE UROKINASE RECEPTOR SUBSTITUTES FOR THE AGONIST-INDUCED CHEMOTACTIC EFFECT

      EMBO journal
    60. BODE C; RUNGE MS; SMALLING RW
      THE FUTURE OF THROMBOLYSIS IN THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION

      European heart journal
    61. FUKAO H; MATSUO O
      CELLULAR FIBRINOLYSIS AND ANGIOGENESIS

      Medicamentos de actualidad
    62. ALONSO DF; FARIAS EF; FAMULARI AL; DOMINGUEZ RO; KOHAN S; DELUSTIG ES
      EXCESSIVE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR ACTIVITY IN THE EUGLOBULIN FRACTION OF PATIENTS WITH ALZHEIMER-TYPE DEMENTIA

      Journal of the neurological sciences
    63. ELLIS V
      FUNCTIONAL-ANALYSIS OF THE CELLULAR RECEPTOR FOR UROKINASE IN PLASMINOGEN ACTIVATION - RECEPTOR BINDING HAS NO INFLUENCE ON THE ZYMOGENIC NATURE OF PRO-UROKINASE

      The Journal of biological chemistry
    64. BEHRENDT N; DANO K
      EFFECT OF PURIFIED, SOLUBLE UROKINASE RECEPTOR ON THE PLASMINOGEN-PROUROKINASE ACTIVATION SYSTEM

      FEBS letters
    65. LIJNEN HR; VANHOFF B; COLLEN D
      CHARACTERIZATION OF THE MURINE PLASMINOGEN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR SYSTEM/

      European journal of biochemistry
    66. RUNGE MS; HARKER LA; BODE C; RUEF J; KELLY AB; MARZEC UM; ALLEN E; CABAN R; SHAW SY; HABER E; HANSON SR
      ENHANCED THROMBOLYTIC AND ANTITHROMBOTIC POTENCY OF A FIBRIN-TARGETEDPLASMINOGEN-ACTIVATOR IN BABOONS

      Circulation
    67. JIANG YP; PANNELL R; LIU JN; GUREWICH V
      EVIDENCE FOR A NOVEL BINDING-PROTEIN TO UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PLATELET MEMBRANES

      Blood
    68. LIU JN; TANG W; SUN ZY; KUNG W; PANNELL R; SARMIENTOS P; GUREWICH V
      A SITE-DIRECTED MUTAGENESIS OF PROUROKINASE WHICH SUBSTANTIALLY REDUCES ITS INTRINSIC ACTIVITY

      Biochemistry
    69. CREDO RB; BURKE SE
      FIBRINOLYTIC MECHANISM, BIOCHEMISTRY, AND PRECLINICAL PHARMACOLOGY OFRECOMBINANT PROUROKINASE

      Journal of vascular and interventional radiology
    70. LIJNEN HR; COLLEN D
      MECHANISMS OF PHYSIOLOGICAL FIBRINOLYSIS

      Bailliere's clinical haematology
    71. RIJKEN DC
      PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS - BIOCHEMICAL ASPECTS

      Bailliere's clinical haematology
    72. CONESE M; BLASI F
      THE UROKINASE UROKINASE-RECEPTOR SYSTEM AND CANCER - INVASION

      Bailliere's clinical haematology
    73. COLLEN D; LIJNEN HR
      NEW THROMBOLYTIC AGENTS AND STRATEGIES

      Bailliere's clinical haematology
    74. GAFFNEY PJ
      STANDARDS IN FIBRINOLYSIS - CURRENT STATUS AND FUTURE CHALLENGES

      Thrombosis and haemostasis
    75. LENICH C; PANNELL R; GUREWICH V
      ASSEMBLY AND ACTIVATION OF THE INTRINSIC FIBRINOLYTIC PATHWAY ON THE SURFACE OF HUMAN ENDOTHELIAL-CELLS IN CULTURE

      Thrombosis and haemostasis
    76. VERSTRAETE M
      THE FIBRINOLYTIC SYSTEM - FROM PETRI DISHES TO GENETIC-ENGINEERING

      Thrombosis and haemostasis
    77. HABER E
      NEW FIBRINOLYTIC AGENTS - FUTURE-DEVELOPMENTS

      Fibrinolysis
    78. BEHRENDT N; RONNE E; DANO K
      THE STRUCTURE AND FUNCTION OF THE UROKINASE RECEPTOR, A MEMBRANE-PROTEIN GOVERNING PLASMINOGEN ACTIVATION ON THE CELL-SURFACE

      Biological chemistry Hoppe-Seyler
    79. CONESE M; BLASI F
      UROKINASE UROKINASE RECEPTOR SYSTEM - INTERNALIZATION/DEGRADATION OF UROKINASE-SERPIN COMPLEXES - MECHANISM AND REGULATION/

      Biological chemistry Hoppe-Seyler
    80. TORCHILIN VP
      TARGETING OF DRUGS AND DRUG CARRIERS WITHIN THE CARDIOVASCULAR-SYSTEM

      Advanced drug delivery reviews
    81. MAKSIMENKO AV
      MOLECULAR-INTERACTIONS IN FIBRINOLYSIS, SEARCH FOR NEW PLASMINOGEN ACTIVATORS (A REVIEW)

      Molecular biology
    82. STAHL A; MUELLER BM
      THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR, A GPI-LINKED PROTEIN, IS LOCALIZED IN CAVEOLAE

      The Journal of cell biology
    83. TAIT JF; ENGELHARDT S; SMITH C; FUJIKAWA K
      PROUROKINASE-ANNEXIN-V CHIMERAS - CONSTRUCTION, EXPRESSION, AND CHARACTERIZATION OF RECOMBINANT PROTEINS

      The Journal of biological chemistry
    84. LIU JN; GUREWICH V
      INACTIVATION OF THE INTRINSIC ACTIVITY OF PROUROKINASE BY DIISOPROPYLFLUOROPHOSPHATE IS REVERSIBLE

      The Journal of biological chemistry
    85. BRETON J; PEZZI N; MOLINARI A; BONOMINI L; LANSEN J; DEBUITRAGO GG; PRIETO I
      PROLONGED HALF-LIFE IN THE CIRCULATION OF A CHEMICAL CONJUGATE BETWEEN A PROUROKINASE DERIVATIVE AND HUMAN SERUM-ALBUMIN

      European journal of biochemistry
    86. VERSTRAETE M; LIJNEN HR; COLLEN D
      THROMBOLYTIC AGENTS IN DEVELOPMENT

      Drugs
    87. RAVON DM; CITARELLA F; LUBBERS YTP; PASCUCCI B; HACK CE
      MONOCLONAL-ANTIBODY F1 BINDS TO THE KRINGLE DOMAIN OF FACTOR-XII AND INDUCES ENHANCED SUSCEPTIBILITY FOR CLEAVAGE BY KALLIKREIN

      Blood
    88. LIJNEN HR; BACHMANN F; COLLEN D; ELLIS V; PANNEKOEK H; RIJKEN DC; THORSEN S
      MECHANISMS OF PLASMINOGEN ACTIVATION

      Journal of internal medicine
    89. COLLEN D; DEBONO DP; LIJNEN HR; PANNEKOEK H
      DEVELOPMENT OF NOVEL THROMBOLYTIC AGENTS

      Journal of internal medicine
    90. GAO Y; HU MH
      PURIFICATION AND CHARACTERIZATION OF RECOMBINANT HUMAN PROUROKINASE PRODUCED IN SILKWORM USING A BACULOVIRUS VECTOR

      Biotechnology techniques
    91. LOZA JP; GUREWICH V; JOHNSTONE M; PANNELL R
      PLATELET-BOUND PREKALLIKREIN PROMOTES PRO-UROKINASE-INDUCED CLOT LYSIS - A MECHANISM FOR TARGETING THE FACTOR-XII DEPENDENT INTRINSIC PATHWAY OF FIBRINOLYSIS

      Thrombosis and haemostasis
    92. KOZLOWSKI KA; BERLET A; ROBBINS KC
      BIOCHEMICAL-PROPERTIES OF VARIANT PLASMINOGENS ASSOCIATED WITH THROMBOPHILIA - DEFECTIVE BINDING AND ACTIVATION OF VARIANT PLASMINOGENS ON THE SURFACE OF MONOCYTOID U937 CELLS

      Fibrinolysis
    93. ROMANOVA EP; GORBUNOVA NA; JITKOVA JV; BASHKOV GV
      ANTI-AGGREGATORY ACTIVITY OF RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR

      Fibrinolysis
    94. DANO K; BEHRENDT N; BRUNNER N; ELLIS V; PLOUG M; PYKE C
      THE UROKINASE RECEPTOR - PROTEIN-STRUCTURE AND ROLE IN PLASMINOGEN ACTIVATION AND CANCER INVASION

      Fibrinolysis
    95. TADA H; KUROKAWA T; SEITA T; WATANABE T; IWASA S
      EXPRESSION AND CHARACTERIZATION OF A CHIMERIC BISPECIFIC ANTIBODY AGAINST FIBRIN AND AGAINST UROKINASE-TYPE PLASMINOGEN-ACTIVATOR

      Journal of biotechnology
    96. WOLF BB; GIBSON CA; KAPUR V; HUSSAINI IM; MUSSER JM; GONIAS SL
      PROTEOLYTICALLY ACTIVE STREPTOCOCCAL PYROGENIC EXOTOXIN-B CLEAVES MONOCYTIC CELL UROKINASE RECEPTOR AND RELEASES AN ACTIVE FRAGMENT OF THE RECEPTOR FROM THE CELL-SURFACE

      The Journal of biological chemistry
    97. LEE SW; ELLIS V; DICHEK DA
      CHARACTERIZATION OF PLASMINOGEN ACTIVATION BY GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED UROKINASE

      The Journal of biological chemistry
    98. DUVALJOBE C; PARMELY MJ
      REGULATION PLASMINOGEN ACTIVATION BY HUMAN U937 PROMONOCYTIC CELLS

      The Journal of biological chemistry
    99. SHIBATA H; NAGAOKA M; SAKAI M; SAWADA H; WATANABE T; YOKOKURA T
      KINETIC-STUDIES ON THE PLASMINOGEN ACTIVATION BY THE STAPHYLOKINASE-PLASMIN COMPLEX

      Journal of Biochemistry
    100. CONFORTI G; DOMINGUEZJIMENEZ C; RONNE E; HOYERHANSEN G; DEJANA E
      CELL-SURFACE PLASMINOGEN ACTIVATION CAUSES A RETRACTION OF IN-VITRO CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELL MONOLAYER

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 22:37:12